SOX9 Antikörper
-
- Target Alle SOX9 Antikörper anzeigen
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SOX9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
- Spezifität
- Recognizes SOX9
- Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
- Aufreinigung
- Purified
- Klon
- 1B11
- Isotyp
- IgG1
- Top Product
- Discover our top product SOX9 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
- Buffer
- PBS, 0.05 % Sodium Azide, 0.5 % protein stabilizer
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
- Target
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
- Andere Bezeichnung
- SOX9 (SOX9 Produkte)
- Hintergrund
- The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.Synonyms: CMD1, CMPD1, SRA1, SRY (sex determining region Y)-box 9, SRY-box 9, Transcription factor SOX-9
- Molekulargewicht
- 56 kDa
- Gen-ID
- 6662
- Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
-